Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Amidation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel lipase Ndbn enables green aromatic amide synthesis with enhanced stability. Offers supply chain reliability and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN111088297B reveals a novel enzymatic route using monoglycerides. Achieves 99% purity, ideal for surfactant and pharma intermediate supply chains.
Patent CN113801903B reveals enzymatic route for sitagliptin intermediate offering high purity and supply chain stability for global API manufacturers.